Intra Cellular Therapies | Ativos



Assets Alterar Data
Acadia Pharmaceuticals USD 1.13B 55.39M 2025-03
ALKERMES USD 2.08B 26.41M 2025-03
Biogen USD 28.03B 16.2M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Cytokinetics USD 1.26B 137.62M 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
Halozyme Therapeutics USD 2.2B 133.06M 2025-03
J&J USD 193.67B 13.57B 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Prothena USD 547.11M 48.15M 2024-12
RedHill Biopharma USD 22.02M 4K 2024-06
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
United Therapeutics USD 7.74B 379.9M 2025-03



Intra Cellular Therapies Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.